Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Coty Inc. (NYSE: COTY) for potential violations of the federal securities laws.If you invested in Coty, you are ...

Cencora, Inc. (NYSE: COR) today announced that its Board of Directors has appointed Lead Independent Director D. Mark Durcan as Chairman of the Board of Directors, effective October 1, 2025. Mr.

As previously communicated, Prothena plans to explore potential partnership interest to advance PRX012 and its preclinical PRX012-TfR (transferrin receptor) antibodyPhase 1 ASCENT clinical program ...

The 2025-2026 COVID-19 vaccine formulation targets the SARS-CoV-2 sublineage LP.8.1, in line with FDA guidance to more ...

Altasciences, a fully integrated CRO/CDMO offering comprehensive early-phase drug development solutions, is pleased to ...

The "Customized Premixes - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering.The global market for customized premixes is estimated at US$1.8 billion in 2024 and is ...

CAMBRIDGE, MA / ACCESS Newswire / August 27, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License ...

Sustained acoustic medicine technology from ZetrOZ Systems will help Patrick Murphy manage soreness and accelerate muscle recovery during his 2,900-mile journey. TRUMBULL, CT / ACCESS Newswire / ...

ABCL575 is an Fc-silenced, half-life extended investigational antibody therapy that is being developed for the treatment of atopic dermatitisVANCOUVER, British Columbia--(BUSINESS ...

The "Brewing Enzymes Market - Types, Sources, Forms and Applications" report has been added to ResearchAndMarkets.com's offering.The global brewing enzymes market is projected to grow from US$534.1 ...

We are pleased to announce that Audacity IB will be honored by The M&A Advisor at the upcoming 16th annual International M&A ...

BOSTON & MONTREAL--(BUSINESS WIRE)--enGene Holdings Inc. (Nasdaq: ENGN or “enGene”), a clinical-stage, non-viral gene therapy company, today announced that management will participate in the following ...